David Lebwohl - 04 Jan 2023 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Signature
James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
04 Jan 2023
Net transactions value
-$95,779
Form type
4
Filing time
06 Jan 2023, 16:26:38 UTC
Previous filing
04 Jan 2023
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale $95,779 -2,574 -9.1% $37.21 25,687 04 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.